Peter V. Danenberg - Publications

Affiliations: 
University of Southern California, Los Angeles, CA, United States 
Area:
Biostatistics Biology, Genetics, Molecular Biology

188 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Raez LE, Danenberg K, Sumarriva D, Usher J, Sands J, Castrellon A, Ferraro P, Milillo A, Huang E, Soon-Shiong P, Reddy S, Danenberg P. Using cfRNA as a tool to evaluate clinical treatment outcomes in patients with metastatic lung cancers and other tumors. Cancer Drug Resistance (Alhambra, Calif.). 4: 1061-1071. PMID 35582387 DOI: 10.20517/cdr.2021.78  0.303
2019 Hodara E, Morrison G, Cunha AT, Zainfeld D, Xu T, Xu Y, Dempsey PW, Pagano PC, Bischoff F, Khurana A, Koo BS, Ting MJ, Cotter PD, Moore MW, Gunn S, ... ... Danenberg P, et al. Multi-parametric liquid biopsy analysis in metastatic prostate cancer. Jci Insight. PMID 30702443 DOI: 10.1172/Jci.Insight.125529  0.34
2019 Sunakawa Y, Usher JL, Jaimes YS, Tsuji A, Shiozawa M, Watanabe T, Satake H, Ota H, Kochi M, Ohori H, Manaka D, Matsuura M, Takeuchi M, Danenberg PV, Fujii M, et al. Clinical verification of circulating tumor RNA (ctRNA) as novel pretreatment predictor and tool for quantitative monitoring of treatment response in metastatic colorectal cancer (mCRC): A biomarker study of the DEEPER trial. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps3621  0.335
2019 Raez LE, Usher JL, Danenberg K, Sumarriva D, Castrellon AB, Rabizadeh S, Milillo A, Hunis B, Reddy S, Huang L, Zikria J, Ferraro P, Danenberg P. RNA-based biomarker signatures in plasma as an independent predictor of outcome to chemotherapy in lung, colon, and breast cancers: Correlation of relative PD-L1 expression with immunotherapy outcomes. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E14567  0.409
2019 Raez L, Usher J, Danenberg K, Sumarriva D, Hunis B, Domingo G, Jaimes Y, Danenberg P, Rabizadeh S. P1.01-68 Monitoring Clinical Responses Measuring PD-L1 in cfRNA in Plasma of Non-Small Cell Lung Cancer Patients Undergoing Systemic Therapy Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.783  0.311
2018 Sunakawa Y, Usher J, Satake H, Jaimes Y, Miyamoto Y, Nakamura M, Kataoka M, Shiozawa M, Takagane A, Terazawa T, Watanabe T, Ishigure K, Tanaka C, Sekikawa T, Takeuchi M, ... ... Danenberg PV, et al. Gene mutation status in circulating tumor DNA (ctDNA) and first-line FOLFOXIRI plus bevacizumab (bev) in metastatic colorectal cancer (mCRC) harboring RAS mutation. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: viii181-viii182. PMID 32136343 DOI: 10.1093/Annonc/Mdy281.089  0.337
2018 Ishiba T, Hoffmann AC, Usher J, Elshimali Y, Sturdevant T, Dang M, Jaimes Y, Tyagi R, Gonzalez R, Grino M, Pinski JK, Barzi A, Raez LE, Eberhardt WE, Theegarten D, ... ... Danenberg PV, et al. Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types. Biochemical and Biophysical Research Communications. PMID 29679564 DOI: 10.1200/Jco.2016.34.15_Suppl.E23101  0.371
2018 Kollengode KA, Grussie E, Danenberg G, Usher JL, Danenberg K, Danenberg P, Pinski JK. Immune checkpoint molecule expression measured using circulating cell-free RNA isolated from the blood of metastatic prostate cancer patients. Journal of Clinical Oncology. 36: 380-380. DOI: 10.1200/Jco.2018.36.6_Suppl.380  0.413
2018 Hodara E, Zainfeld D, Morrison G, Cunha A, Xu Y, Carpten JD, Danenberg PV, Dempsey PW, Usher J, DANENBERG K, Bischoff FZ, Khurana A, Cotter PD, Moore M, Gunn S, et al. Multi-parametric liquid biopsy analysis of circulating tumor cells (CTCs), cell-free DNA (cfDNA), and cell-free RNA (cfRNA) in metastatic castrate resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 36: 274-274. DOI: 10.1200/Jco.2018.36.6_Suppl.274  0.378
2018 Grussie E, Danenberg G, Kollengode KA, Danenberg K, Rabizadeh S, Huang E, Usher JL, Danenberg PV, Pinski JK. Gene expression differences in cell-free RNA between prostate cancer patients and healthy individuals. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E17077  0.382
2018 Raez LE, Danenberg K, Castrellon AB, Velez M, Usher JL, Rabizadeh S, Jaimes YS, Hunis B, Habaue C, Danenberg P. Use of cell-free circulating RNA (cfRNA) levels in plasma and expression of HER2 and PD-L1 to monitor disease status in metastatic cancer patients. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E15013  0.403
2018 Castrellon A, Velez M, Raez L, Danenberg K, Rabizadeh S, Usher J, Jaimes Y, Hunis B, Bittencourt A, Milillo A, Blaya M, Habaue C, Danenberg P. Abstract P2-02-16: Use of cell-free circulating RNA and expression of PD-L1 and HER2 in plasma to monitor and predict clinical response in metastatic breast cancer patients Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P2-02-16  0.344
2017 Raez LE, Danenberg K, Castrellon AB, Usher JL, Jaimes YS, Hunis B, Velez ME, Habaue C, Danenberg P. Correlation of cell-free circulating DNA, RNA, and PD-L1 from plasma with clinical response in patients with metastatic lung and breast cancers. Journal of Clinical Oncology. 35: 11550-11550. DOI: 10.1200/Jco.2017.35.15_Suppl.11550  0.41
2017 Raez L, Danenberg K, Hunis B, Castrellon A, Jaimes Y, Velez M, Usher J, Habaue C, Danenberg P. P2.03b-039 Cell-Free (cf) DNA and cfRNA levels in Plasma of Lung Cancer Patients Indicate Disease Status and Predict Progression: Topic: Biomarkers Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2016.11.1320  0.337
2015 Danenberg K, Lenz H, Usher J, Zhang W, El-khoueiry R, Li J, Elshimali Y, Huang X, Dang M, Sturdevant T, Jaimes Y, Findlater R, Grino M, Danenberg P. 2008 Non-Invasive testing of gene expressions using cell-free RNA increases the chemotherapy target information generated from cell-free DNA testing European Journal of Cancer. 51: S330. DOI: 10.1016/S0959-8049(16)30933-9  0.333
2013 Jensen LH, Rasmussen AA, Byriel L, Kuramochi H, Crüger DG, Lindebjerg J, Danenberg PV, Jakobsen A, Danenberg K. Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study. Cellular Oncology (Dordrecht). 36: 411-9. PMID 24027018 DOI: 10.1007/S13402-013-0148-2  0.414
2013 Hoffmann AC, Goekkurt E, Danenberg PV, Lehmann S, Ehninger G, Aust DE, Stoehlmacher-Williams J. EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma. Plos One. 8: e64186. PMID 23704979 DOI: 10.1371/Journal.Pone.0064186  0.432
2013 Wilson PM, Yang D, Azuma M, Shi MM, Danenberg KD, Lebwohl D, Sherrod A, Ladner RD, Zhang W, Danenberg PV, Trarbach T, Folprecht G, Meinhardt G, Lenz HJ. Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib). The Pharmacogenomics Journal. 13: 410-6. PMID 22664478 DOI: 10.1038/tpj.2012.23  0.348
2012 Grimminger PP, Maus MK, Schneider PM, Metzger R, Hölscher AH, Sugita H, Danenberg PV, Alakus H, Brabender J. Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC. Lung Cancer (Amsterdam, Netherlands). 78: 87-91. PMID 22884253 DOI: 10.1016/J.Lungcan.2012.07.008  0.416
2012 Kornmann M, Hebart H, Danenberg K, Goeb R, Staib L, Kron M, Henne-Bruns D, Danenberg P, Link KH. Response prediction in metastasised colorectal cancer using intratumoural thymidylate synthase: Results of a randomised multicentre trial European Journal of Cancer. 48: 1443-1451. PMID 22133572 DOI: 10.1016/J.Ejca.2011.11.007  0.383
2012 Grimminger PP, Shi M, Barrett C, Lebwohl D, Danenberg KD, Brabender J, Vigen CLP, Danenberg PV, Winder T, Lenz HJ. TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and-2 clinical trials Pharmacogenomics Journal. 12: 404-411. PMID 21788964 DOI: 10.1038/Tpj.2011.29  0.414
2012 Azzoli CG, Drilon AEDC, Sugita H, Sima CS, Huang E, Danenberg PV, Kris MG, Rusch VW. Prospective study of tumor suppressor gene (TSG) methylation as a prognostic biomarker in surgically resected non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 30: 7066-7066. DOI: 10.1200/Jco.2012.30.15_Suppl.7066  0.367
2011 Li T, Mack PC, Desai S, Kelly K, Cooc J, Danenberg PV, Danenberg KD, Gandara DR. Large-scale screening of ALK fusion oncogene transcripts in archival NSCLC tumor specimens using multiplexed RT-PCR assays. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 10520. PMID 28021750 DOI: 10.1200/Jco.2011.29.15_Suppl.10520  0.333
2011 Kelly K, Mack P, Huang X, Lara P, Danenberg PV, Danenberg KD, Gandara DR. BRCA1 mRNA expression patterns in a large lung cancer cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 7056. PMID 28020036 DOI: 10.1200/Jco.2011.29.15_Suppl.7056  0.443
2011 Jensen LH, Kuramochi H, Crüger DG, Lindebjerg J, Kolvraa S, Danenberg P, Danenberg K, Jakobsen A. Gene expression of the mismatch repair gene MSH2 in primary colorectal cancer Tumor Biology. 32: 977-983. PMID 21732224 DOI: 10.1007/S13277-011-0199-9  0.453
2011 Grimminger PP, Danenberg P, Dellas K, Arnold D, Rödel C, Machiels J, Haustermans K, Debucquoy A, Velenik V, Sempoux C, Bracko M, Hölscher AH, Semrau R, Yang D, Danenberg K, et al. Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer Clinical Cancer Research. 17: 3469-3477. PMID 21558395 DOI: 10.1158/1078-0432.Ccr-10-2273  0.443
2011 Grimminger CM, Danenberg PV. Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (Eufos) : Affiliated With the German Society For Oto-Rhino-Laryngology - Head and Neck Surgery. 268: 5-16. PMID 20827554 DOI: 10.1007/S00405-010-1369-X  0.38
2011 Goekkurt E, Stoehlmacher J, Aust DE, Danenberg PV, Danenberg KD, Lehmann S, Mogck U, Ehninger G, Hoffmann AC. VEGF receptor 1 and heparanase expression as prognostic factors in cholangiocellular carcinoma. Journal of Clinical Oncology. 29: 226-226. DOI: 10.1200/Jco.2011.29.4_Suppl.226  0.448
2010 Gandara DR, Grimminger P, Mack PC, Lara PN, Li T, Danenberg PV, Danenberg KD. Association of epidermal growth factor receptor activating mutations with low ERCC1 gene expression in non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 1933-8. PMID 20975603 DOI: 10.1097/Jto.0B013E3181Fd418D  0.367
2010 Grimminger PP, Schneider PM, Metzger R, Vallböhmer D, Hölscher AH, Danenberg PV, Brabender J. Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer. Clinical Lung Cancer. 11: 328-34. PMID 20837458 DOI: 10.3816/Clc.2010.N.041  0.465
2010 Hoffmann AC, Wild P, Leicht C, Bertz S, Danenberg KD, Danenberg PV, Stöhr R, Stöckle M, Lehmann J, Schuler M, Hartmann A. MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. Neoplasia (New York, N.Y.). 12: 628-36. PMID 20689757 DOI: 10.1593/Neo.10402  0.413
2010 Mori R, Dorff TB, Xiong S, Tarabolous CJ, Ye W, Groshen S, Danenberg KD, Danenberg PV, Pinski JK. The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes. The Prostate. 70: 1692-700. PMID 20564320 DOI: 10.1002/Pros.21204  0.401
2010 Grimminger PP, Schneider PM, Metzger R, Vallböhmer D, Danenberg KD, Danenberg PV, Hölscher AH, Brabender J. Ornithine decarboxylase mRNA expression in curatively resected non-small-cell lung cancer. Clinical Lung Cancer. 11: 114-9. PMID 20199977 DOI: 10.3816/Clc.2010.N.015  0.45
2010 Grimminger PP, Schneider PM, Metzger R, Vallböhmer D, Danenberg KD, Danenberg PV, Hölscher AH, Brabender J. The prognostic role of Bcl-2 mRNA expression in curatively resected non-small cell lung cancer (NSCLC). Lung Cancer (Amsterdam, Netherlands). 70: 82-7. PMID 20064672 DOI: 10.1016/J.Lungcan.2009.12.013  0.46
2010 Kuramochi H, Hayashi K, Nakajima G, Kamikozuru H, Yamamoto M, Danenberg KD, Danenberg PV. Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases. Cancer Chemotherapy and Pharmacology. 65: 825-31. PMID 19701635 DOI: 10.1007/S00280-009-1087-5  0.387
2010 Gandara DR, Grimminger PP, Mack PC, Danenberg PV, Lara P, Danenberg KD. Histology- and gender-related associations of ERCC1, RRM1, and TS biomarkers in 1,802 patients with NSCLC: Implications for therapy. Journal of Clinical Oncology. 28: 7513-7513. DOI: 10.1200/Jco.2010.28.15_Suppl.7513  0.438
2010 Ladner RD, Ulrich CM, Rankin CJ, Danenberg KD, Danenberg PV, Smalley SR, Makar KW, Benedetti JK, Blanke CD, Lenz H. Association of intratumoral gene expression levels of thymidine phosphorylase (TP) and VEGF with clinical outcome in stage II/III rectal cancer patients treated with 5-fluorouracil and pelvic radiation in a phase III intergroup trial (SWOG 9304). Journal of Clinical Oncology. 28: 3640-3640. DOI: 10.1200/Jco.2010.28.15_Suppl.3640  0.345
2010 Vallbohmer D, Grimminger PP, Yang D, Danenberg KD, Danenberg P, Arnold D, Machiels JH, Roedel C, Velenik V, Lenz H. Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in advanced rectal cancer. Journal of Clinical Oncology. 28: 3563-3563. DOI: 10.1200/Jco.2010.28.15_Suppl.3563  0.347
2010 Danenberg PV, Stephens C, Cooc J, Gandara DR, Mack PC, Grimminger PP, Danenberg KD. A novel RT-PCR approach to detecting EML4-ALK fusion genes in archival NSCLC tissue. Journal of Clinical Oncology. 28: 10535-10535. DOI: 10.1200/Jco.2010.28.15_Suppl.10535  0.349
2010 Danenberg KD, Grimminger PP, Mack PC, Danenberg PV, Cooc J, Stephens C, Reddy SK, Li T, Gandara DR. KRAS mutations (MTs) in non-small cell lung cancer (NSCLC) versus colorectal cancer (CRC): Implications for cetuximab therapy. Journal of Clinical Oncology. 28: 10529-10529. DOI: 10.1200/Jco.2010.28.15_Suppl.10529  0.378
2010 Grimminger PP, Shi M, Barrett JC, Lebwohl DE, Danenberg KD, Vigen CL, Yang D, Brabender J, Danenberg PV, Lenz H. Association of TS and ERCC1 mRNA expressions with overall survival in patients enrolled in CONFIRM 1 and 2. Journal of Clinical Oncology. 28: 10522-10522. DOI: 10.1200/Jco.2010.28.15_Suppl.10522  0.405
2010 Hoffmann AC, Bertz S, Stöhr R, Wild PJ, Lehmann J, Danenberg KD, Danenberg PV, Schuler M, Hartmann A. Abstract 2693: MDR1 and ERCC1 expression predict outcome in patients with locally advanced bladder cancer and adjuvant chemotherapy Cancer Research. 70: 2693-2693. DOI: 10.1158/1538-7445.Am10-2693  0.463
2010 Somlo G, Frankel P, Cooc J, Lau S, Danenberg K, Yim J, Danenberg P. Abstract P2-09-17: Limited Gene Expression Profiling as Predictor of Response to Neoadjuvant Chemotherapy (NCT) with Docetaxel, Doxorubicin, Cyclophosphamide (TAC), or AC and Nab-Paclitaxel and Carboplatin +/− Trastuzumab in Patients (pts) with Locally Advanced (LABC) Stage II-III and Inflammatory Breast Cancer (IBC) Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P2-09-17  0.374
2009 Grimminger PP, Stöhlmacher J, Vallböhmer D, Schneider PM, Hölscher AH, Metzger R, Danenberg PV, Brabender J. Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer. Journal of Oncology. 2009: 139590. PMID 20016751 DOI: 10.1155/2009/139590  0.338
2009 Hoffmann AC, Hoffman AC, Danenberg KD, Taubert H, Danenberg PV, Wuerl P. A three-gene signature for outcome in soft tissue sarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5191-8. PMID 19671876 DOI: 10.1158/1078-0432.Ccr-08-2534  0.32
2009 Kuramochi H, Uchida K, Peters JH, Shimizu D, Vallbohmer D, Schneider S, Danenberg KD, Danenberg PV. Loss of heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences. Bmc Cancer. 9: 157. PMID 19460136 DOI: 10.1186/1471-2407-9-157  0.339
2009 Kobayashi H, Sugihara K, Uetake H, Higuchi T, Yasuno M, Enomoto M, Iida S, Lenz HJ, Danenberg KD, Danenberg PV. Messenger RNA expression of COX-2 and angiogenic factors in primary colorectal cancer and corresponding liver metastasis. International Journal of Oncology. 34: 1147-53. PMID 19287974 DOI: 10.3892/Ijo_00000243  0.393
2009 Ohta S, Uemura H, Matsui Y, Ishiguro H, Fujinami K, Kondo K, Miyamoto H, Yazawa T, Danenberg K, Danenberg PV, Tohnai I, Kubota Y. Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 107: 81-91. PMID 19101490 DOI: 10.1016/J.Tripleo.2008.08.027  0.346
2009 Mori R, Xiong S, Wang Q, Tarabolous C, Shimada H, Panteris E, Danenberg KD, Danenberg PV, Pinski JK. Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells. The Prostate. 69: 12-23. PMID 18814146 DOI: 10.1002/Pros.20851  0.302
2009 Oh DS, DeMeester SR, Dunst CM, Mori R, Lehman BJ, Kuramochi H, Danenberg K, Danenberg P, Hagen JA, Chandrasoma P, DeMeester TR. Validation of a rodent model of Barrett's esophagus using quantitative gene expression profiling. Surgical Endoscopy. 23: 1346-52. PMID 18813976 DOI: 10.1007/S00464-008-0169-5  0.323
2009 Hoffman AC, Wild P, Gauler T, Leicht C, Bertz S, Danenberg KD, Danenberg PV, Stöhr R, Stöckle M, Lehmann J, Hartmann A. Correlation of multidrug-resistance gene (MDR1) expression levels and outcome to adjuvant cisplatin/MTX based chemotherapy in patients enrolled in the AUO-AB 05/95 phase III trial Journal of Clinical Oncology. 27: 5026-5026. DOI: 10.1200/Jco.2009.27.15_Suppl.5026  0.453
2008 Collisson EA, Das D, Mori R, Hoffmann AC, Kim GE, Hajnal R, Danenberg PV, Cooc J, Danenberg KD, Tempero MA. Use of whole genome expression analysis of pancreatic adenocarcinoma to predict prognosis after OXi4503 surgery. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4503. PMID 27949218 DOI: 10.1200/Jco.2008.26.15_Suppl.4503  0.381
2008 Mori R, Collisson EA, Hoffmann AC, Kim GE, Shimada H, Togo S, Danenberg PV, Cooc J, Danenberg KD, Tempero MA. Different pancreatic cancer genomic risk prediction models derived from microdissected and non-microdissected paraffin-embedded tissue. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4622. PMID 27948548 DOI: 10.1200/Jco.2008.26.15_Suppl.4622  0.394
2008 Omori A, Hoffmann AC, Shi MM, Lenz HJ, Michie CO, Gourley CM, Cooc J, Clark JS, Danenberg KD, Danenberg PV. Use of ERCC1 gene expression to predict the effectiveness of platin-based therapy in colorectal, ovarian and lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 2541. PMID 27947932 DOI: 10.1200/Jco.2008.26.15_Suppl.2541  0.453
2008 Uchida K, Danenberg PV, Danenberg KD, Grem JL. Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine. Bmc Cancer. 8: 386. PMID 19105824 DOI: 10.1186/1471-2407-8-386  0.429
2008 Fukui Y, Oka T, Nagayama S, Danenberg PV, Danenberg KD, Fukushima M. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis. International Journal of Molecular Medicine. 22: 709-16. PMID 19020767 DOI: 10.3892/Ijmm_00000076  0.431
2008 Kobayashi H, Sugihara K, Uetake H, Higuchi T, Yasuno M, Enomoto M, Iida S, Azuma M, Mori R, Omori A, Lenz HJ, Danenberg KD, Danenberg PV. Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis. International Journal of Oncology. 33: 1257-62. PMID 19020759 DOI: 10.3892/Ijo_00000116  0.411
2008 Hoffmann AC, Mori R, Vallbohmer D, Brabender J, Drebber U, Baldus SE, Klein E, Azuma M, Metzger R, Hoffmann C, Hoelscher AH, Danenberg KD, Prenzel KL, Danenberg PV. High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIF1a to HB-EGF and bFGF. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 12: 1674-81; discussion . PMID 18704599 DOI: 10.1016/S0016-5085(08)64009-3  0.302
2008 Makino H, Uetake H, Danenberg K, Danenberg PV, Sugihara K. Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer. Bmc Cancer. 8: 210. PMID 18652704 DOI: 10.1186/1471-2407-8-210  0.414
2008 Mori R, Wang Q, Danenberg KD, Pinski JK, Danenberg PV. Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer. The Prostate. 68: 1555-60. PMID 18651557 DOI: 10.1002/Pros.20815  0.371
2008 Somlo G, Chu P, Frankel P, Ye W, Groshen S, Doroshow JH, Danenberg K, Danenberg P. Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome Annals of Oncology. 19: 1853-1859. PMID 18641005 DOI: 10.1093/Annonc/Mdn402  0.403
2008 Hoffmann AC, Mori R, Vallbohmer D, Brabender J, Klein E, Drebber U, Baldus SE, Cooc J, Azuma M, Metzger R, Hoelscher AH, Danenberg KD, Prenzel KL, Danenberg PV. High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF. Neoplasia (New York, N.Y.). 10: 674-9. PMID 18592007 DOI: 10.1593/Neo.08292  0.462
2008 Banki F, Yacoub WN, Hagen JA, Mason RJ, Ayazi S, DeMeester SR, Lipham JC, Danenberg K, Danenberg P, DeMeester TR. Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer. Journal of the American College of Surgeons. 207: 30-5. PMID 18589358 DOI: 10.1016/J.Jamcollsurg.2008.01.004  0.33
2008 Theisen J, Danenberg K, Ott K, Becker K, Danenberg P, Stein HJ, Siewert JR. Predictors of response and survival for neoadjuvant treated patients with esophageal adenocarcinoma. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus / I.S.D.E. 21: 601-6. PMID 18430179 DOI: 10.1111/J.1442-2050.2008.00820.X  0.41
2008 Kuramochi H, Hayashi K, Uchida K, Nakajima G, Hatori T, Danenberg KD, Danenberg PV, Yamamoto M. High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1. Cancer Chemotherapy and Pharmacology. 63: 85-9. PMID 18309485 DOI: 10.1007/S00280-008-0714-X  0.397
2008 Kobayashi H, Sugihara K, Uetake H, Higuchi T, Yasuno M, Enomoto M, Kuramochi H, Lenz HJ, Danenberg KD, Danenberg PV. Messenger RNA expression of vascular endothelial growth factor and its receptors in primary colorectal cancer and corresponding liver metastasis. Annals of Surgical Oncology. 15: 1232-8. PMID 18239970 DOI: 10.1245/S10434-008-9811-7  0.368
2008 Kuramochi H, Tanaka K, Oh D, Lehman BJ, Dunst CM, Yang DY, Meester SRD, Hagen JA, Danenberg KD, Meester TRD, Danenberg PV. Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients. International Journal of Oncology. 32: 201-208. DOI: 10.3892/Ijo.32.1.201  0.405
2008 Morita S, Inokuchi M, Hoffmann AC, Cooc J, Omori A, Danenberg PV, Danenberg KD, Uetake H. Use of molecular signatures of gastric cancers derived from microarray analysis of paraffin-embedded specimens to predict the degree of response to CPT11/S-1 chemotherapy Journal of Clinical Oncology. 26: 4566-4566. DOI: 10.1200/Jco.2008.26.15_Suppl.4566  0.371
2008 Zhang W, Rankin CJ, Danenberg KD, Benedetti JK, Danenberg PV, Ulrich CM, Holmes RS, Makar KW, Blanke CD, Smalley SR, Lenz HJ. An update of pharmacogenetic analysis of adjuvant rectal cancer patients treated with 5-fluorouracil and pelvic radiation in a phase III intergroup trial (INT-0144, SWOG 9304) Journal of Clinical Oncology. 26: 4115-4115. DOI: 10.1200/Jco.2008.26.15_Suppl.4115  0.42
2008 Hoffmann AC, Wettergren Y, Odin E, Carlsson G, Omori A, Cooc J, Danenberg KD, Danenberg PV, Gustavsson B. Derivation of genomic risk models for early relapse in colorectal cancer from microdissected FFPE tumor and from mucosal tissue Journal of Clinical Oncology. 26: 15126-15126. DOI: 10.1200/Jco.2008.26.15_Suppl.15126  0.369
2008 Kuramochi H, Hayashi K, Nakajima G, Danenberg KD, Danenberg PV, Yamamoto M. The relationship between epidermal growth factor receptor (EGFR) mRNA levels and protein expression in primary colorectal cancer and corresponding liver metastases Journal of Clinical Oncology. 26: 15021-15021. DOI: 10.1200/Jco.2008.26.15_Suppl.15021  0.399
2008 Oh DS, DeMeester SR, Mori R, Kuramochi H, Hagen JA, Lipham JC, Chandrasoma P, Danenberg PV, Danenberg KD, DeMeester TR. 997 Sonic Hedgehog Gene Expression in Barrett's Esophagus and Esophageal Adenocarcinoma Gastroenterology. 134. DOI: 10.1016/S0016-5085(08)60697-6  0.37
2007 Azuma M, Shi M, Danenberg KD, Gardner H, Barrett C, Jacques CJ, Sherod A, Iqbal S, El-Khoueiry A, Yang D, Zhang W, Danenberg PV, Lenz HJ. Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients. Pharmacogenomics. 8: 1705-13. PMID 18086000 DOI: 10.2217/14622416.8.12.1705  0.425
2007 Vallböhmer D, Marjoram P, Kuramochi H, Shimizu D, Jung H, DeMeester SR, Oh D, Chandrasoma PT, Danenberg KD, DeMeester TR, Danenberg PV, Peters JH. Towards the molecular characterization of disease: comparison of molecular and histological analysis of esophageal epithelia. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 11: 1095-104. PMID 17623264 DOI: 10.1007/S11605-007-0208-X  0.397
2007 Vallböhmer D, Yang DY, Kuramochi H, Shimizu D, Danenberg KD, Lindebjerg J, Nielsen JN, Jakobsen A, Danenberg PV. DPD is a molecular determinant of capecitabine efficacy in colorectal cancer. International Journal of Oncology. 31: 413-8. PMID 17611699 DOI: 10.3892/Ijo.31.2.413  0.461
2007 Oh DS, DeMeester SR, Vallbohmer D, Mori R, Kuramochi H, Hagen JA, Lipham J, Danenberg KD, Danenberg PV, Chandrasoma P, DeMeester TR. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery. Archives of Surgery (Chicago, Ill. : 1960). 142: 554-9; discussion 55. PMID 17576892 DOI: 10.1001/Archsurg.142.6.554  0.366
2007 Banki F, Mason RJ, Oh D, Hagen JA, DeMeester SR, Lipham JC, Tanaka K, Danenberg KD, Yacoub WN, Danenberg PV, DeMeester TR. Plasma DNA as a molecular marker for completeness of resection and recurrent disease in patients with esophageal cancer. Archives of Surgery (Chicago, Ill. : 1960). 142: 533-8; discussion 53. PMID 17576889 DOI: 10.1001/Archsurg.142.6.533  0.32
2007 Jensen LH, Danenberg KD, Danenberg PV, Jakobsen A. Predictive value of MSH2 gene expression in colorectal cancer treated with capecitabine. Clinical Colorectal Cancer. 6: 433-5. PMID 17531106 DOI: 10.3816/Ccc.2007.N.012  0.416
2007 Mori R, Ishikawa T, Ichikawa Y, Taniguchi K, Matsuyama R, Ueda M, Fujii Y, Endo I, Togo S, Danenberg PV, Shimada H. Human equilibrative nucleoside transporter 1 is associated with the chemosensitivity of gemcitabine in human pancreatic adenocarcinoma and biliary tract carcinoma cells. Oncology Reports. 17: 1201-5. PMID 17390066 DOI: 10.3892/Or.17.5.1201  0.321
2007 Oh DS, Cooc J, DeMeester SR, Mori R, Kuramochi H, Rizzetto C, Danenberg K, Danenberg P, Hagen JA, Harpole DH, DeMeester TR. Molecular signature of esophageal adenocarcinoma derived from microarray analysis of paraffin-embedded specimens predicts systemic recurrence following resection Journal of Clinical Oncology. 25: 4563-4563. DOI: 10.1200/Jco.2007.25.18_Suppl.4563  0.343
2007 Azuma M, Yang D, Carpanu M, Hollywood E, Lue-Yat M, Zhang W, Danenberg KD, Danenberg PV, Saltz L, Lenz H. Molecular markers associated with response and clinical outcome to cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer (BOND2) Journal of Clinical Oncology. 25: 4113-4113. DOI: 10.1200/Jco.2007.25.18_Suppl.4113  0.305
2007 Kuramochi H, Hayashi K, Uchida K, Yamamoto M, Danenberg KD, Danenberg PV. Epidermal growth factor receptor (EGFR) mRNA expression levels are strongly correlated between primary colorectal cancer and corresponding liver metastases Journal of Clinical Oncology. 25: 4106-4106. DOI: 10.1200/Jco.2007.25.18_Suppl.4106  0.414
2007 Banki F, Hagen JA, Mason RJ, DeMeester SR, Oh D, Yacoub WN, Danenberg PV, DeMeester TR. Plasma DNA: A molecular marker for the pattern of dissemination of esophageal cancer Journal of Clinical Oncology. 25: 21015-21015. DOI: 10.1200/Jco.2007.25.18_Suppl.21015  0.32
2007 Uetake H, Inokuchi M, Sugihara K, Danenberg K, Danenberg PV. Microarray analysis using paraffin embedded samples of gastric cancer (GC) Journal of Clinical Oncology. 25: 15089-15089. DOI: 10.1200/Jco.2007.25.18_Suppl.15089  0.309
2007 Hoffmann AC, Hoffmann C, Danenberg KD, Lenz HJ, Danenberg PV. Heparanase and Survivin--potential markers of aggressiveness of colon cancers Journal of Clinical Oncology. 25: 14524-14524. DOI: 10.1200/Jco.2007.25.18_Suppl.14524  0.469
2007 Jensen LH, Danenberg KD, Danenberg PV, Jakobsen A. Predictive value of MSH2 gene expression in colorectal cancer treated with capecitabine Clinical Colorectal Cancer. 6: 433-435.  0.376
2006 Yang D, Schneider S, Azuma M, Iqbal S, El-Khoueiry A, Groshen S, Agafitei D, Danenberg KD, Danenberg PV, Ladner RD, Lenz HJ. Gene expression levels of epidermal growth factor receptor, survivin, and vascular endothelial growth factor as molecular markers of lymph node involvement in patients with locally advanced rectal cancer. Clinical Colorectal Cancer. 6: 305-11. PMID 17241515 DOI: 10.3816/Ccc.2006.N.049  0.354
2006 Azuma M, Danenberg KD, Iqbal S, El-Khoueiry A, Zhang W, Yang D, Koizumi W, Saigenji K, Danenberg PV, Lenz HJ. Epidermal growth factor receptor and epidermal growth factor receptor variant III gene expression in metastatic colorectal cancer. Clinical Colorectal Cancer. 6: 214-8. PMID 17026791 DOI: 10.3816/Ccc.2006.N.038  0.376
2006 Ceppi P, Volante M, Novello S, Rapa I, Danenberg KD, Danenberg PV, Cambieri A, Selvaggi G, Saviozzi S, Calogero R, Papotti M, Scagliotti GV. ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine Annals of Oncology. 17: 1818-1825. PMID 16980606 DOI: 10.1093/Annonc/Mdl300  0.439
2006 Rubio-Viqueira B, Jimeno A, Cusatis G, Zhang X, Iacobuzio-Donahue C, Karikari C, Shi C, Danenberg K, Danenberg PV, Kuramochi H, Tanaka K, Singh S, Salimi-Moosavi H, Bouraoud N, Amador ML, et al. An in vivo platform for translational drug development in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 4652-61. PMID 16899615 DOI: 10.1158/1078-0432.Ccr-06-0113  0.329
2006 Vallböhmer D, Brabender J, Yang D, Schneider PM, Metzger R, Danenberg KD, Hölscher AH, Danenberg PV. DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value. Clinical Lung Cancer. 8: 39-44. PMID 16870044 DOI: 10.3816/Clc.2006.N.031  0.447
2006 Vallböhmer D, DeMeester SR, Peters JH, Oh DS, Kuramochi H, Shimizu D, Hagen JA, Danenberg KD, Danenberg PV, DeMeester TR, Chandrasoma PT. Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus / I.S.D.E. 19: 260-6. PMID 16866857 DOI: 10.1111/J.1442-2050.2006.00586.X  0.35
2006 Vallböhmer D, DeMeester SR, Oh DS, Banki F, Kuramochi H, Shimizu D, Hagen JA, Danenberg KD, Danenberg PV, Chandrasoma PT, Peters JH, DeMeester TR. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus. The American Journal of Gastroenterology. 101: 1458-66. PMID 16863546 DOI: 10.1111/J.1572-0241.2006.00601.X  0.415
2006 Dziadziuszko R, Witta SE, Cappuzzo F, Park S, Tanaka K, Danenberg PV, Barón AE, Crino L, Franklin WA, Bunn PA, Varella-Garcia M, Danenberg KD, Hirsch FR. Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3078-84. PMID 16707605 DOI: 10.1158/1078-0432.Ccr-06-0106  0.401
2006 Vallböhmer D, Peters JH, Kuramochi H, Oh D, Yang D, Shimizu D, DeMeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, Danenberg PV, DeMeester TR. Molecular determinants in targeted therapy for esophageal adenocarcinoma. Archives of Surgery (Chicago, Ill. : 1960). 141: 476-81; discussion 4. PMID 16702519 DOI: 10.1001/Archsurg.141.5.476  0.384
2006 Vallböhmer D, Brabender J, Yang DY, Danenberg K, Schneider PM, Metzger R, Holscher AH, Danenberg PV. Sex differences in the predictive power of the molecular prognostic factor HER2/neu in patients with non-small-cell lung cancer. Clinical Lung Cancer. 7: 332-7. PMID 16640805 DOI: 10.3816/Clc.2006.N.015  0.399
2006 Kuramochi H, Hayashi K, Uchida K, Miyakura S, Shimizu D, Vallbohmer D, Park S, Danenberg KD, Takasaki K, Danenberg PV. 5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis. International Journal of Cancer. 119: 522-6. PMID 16572420 DOI: 10.1200/Jco.2005.23.16_Suppl.3568  0.429
2006 Shimizu D, Vallböhmer D, Kuramochi H, Uchida K, Schneider S, Chandrasoma PT, Shimada H, DeMeester TR, Danenberg KD, Peters JH, DeMeester SR, Danenberg PV. Increasing cyclooxygenase-2 (cox-2) gene expression in the progression of Barrett's esophagus to adenocarcinoma correlates with that of Bcl-2. International Journal of Cancer. Journal International Du Cancer. 119: 765-70. PMID 16550596 DOI: 10.1002/Ijc.21922  0.398
2006 Odin E, Wettergren Y, Carlsson G, Danenberg PV, Termini A, Willén R, Gustavsson B. Expression and clinical significance of methylenetetrahydrofolate reductase in patients with colorectal cancer. Clinical Colorectal Cancer. 5: 344-9. PMID 16512993 DOI: 10.3816/Ccc.2006.N.004  0.403
2006 Kuramochi H, Hayashi K, Uchida K, Miyakura S, Shimizu D, Vallböhmer D, Park S, Danenberg KD, Takasaki K, Danenberg PV. Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 29-33. PMID 16397020 DOI: 10.1158/1078-0432.Ccr-05-1275  0.35
2006 Vallböhmer D, Kuramochi H, Shimizu D, Danenberg KD, Lindebjerg J, Nielsen JN, Jakobsen A, Danenberg PV. Molecular factors of 5-fluorouracil metabolism in colorectal cancer: Analysis of primary tumor and lymph node metastasis International Journal of Oncology. 28: 527-533. DOI: 10.3892/Ijo.28.2.527  0.385
2006 Joshi MM, Petersen RP, Conlon DH, Tanaka K, Shimizu D, Kuramochi H, Williams M, Danenberg PV, Danenberg KD, Harpole DH. Differential canonical pathways derived from microarrays using RNA from paraffin-embedded non-small cell lung cancer tissue Journal of Clinical Oncology. 24: 7226-7226. DOI: 10.1200/Jco.2006.24.18_Suppl.7226  0.384
2006 Azzoli CG, Park S, Ginex P, Vincent A, Jones J, Venkatraman E, Danenberg K, Danenberg P, Rusch VR, Kris MG. Interim results of two prospective trials measuring plasma total DNA and methylated genes before and after surgery, or chemotherapy, in patients with non-small cell lung cancer (NSCLC) Journal of Clinical Oncology. 24: 7123-7123. DOI: 10.1200/Jco.2006.24.18_Suppl.7123  0.371
2006 Shimizu D, Kuramochi H, Tanaka K, Cooc J, Xiong Y, William M, Li R, Danenberg KD, Danenberg PV, Lenz HJ. Molecular signatures generated with RNA isolated from formalin-fixed paraffin-embedded tumor specimens differentiate metastatic and non-metastatic primary colorectal cancer Journal of Clinical Oncology. 24: 3615-3615. DOI: 10.1200/Jco.2006.24.18_Suppl.614  0.423
2006 Kuramochi H, Tanaka K, Lehman BJ, Dunst CM, Oh DS, Demeester SR, Hagen JA, Danenberg KD, Demeester TR, Danenberg PV. Thymidylate synthase polymorphisms and its mRNA expression levels as independent chemo-predictive markers in esophageal adenocarcinoma patients receiving 5-fluorouracil chemotherapy Journal of Clinical Oncology. 24: 4063-4063. DOI: 10.1200/Jco.2006.24.18_Suppl.4063  0.354
2006 Kobayashi H, Hashiguchi Y, Ueno H, Shinto E, Kajiwara Y, Lenz H, Danenberg KD, Danenberg PV, Mochizuki H. Pretreatment COX-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy Journal of Clinical Oncology. 24: 3610-3610. DOI: 10.1200/Jco.2006.24.18_Suppl.3610  0.416
2006 Vallbohmer D, Kuramochi H, Shimizu D, Danenberg KD, Nielsen JN, Lindebjerg J, Jakobsen A, Danenberg PV. Molecular determinants of capecitabine efficacy in colorectal cancer Journal of Clinical Oncology. 24: 3606-3606. DOI: 10.1200/Jco.2006.24.18_Suppl.3606  0.338
2006 Jensen LH, Jakobsen A, Kuramochi H, Liu B, Stephen CL, Cruger DG, Aggerholm A, Lindebjerg J, Danenberg PV, Danenberg KD. Gene expression of MLH1 related to microsatellite instability, immuno-histochemistry, and promoter hypermethylation in colorectal cancer Journal of Clinical Oncology. 24: 3601-3601. DOI: 10.1200/Jco.2006.24.18_Suppl.3601  0.377
2006 Grem JL, Nguyen D, Uchida K, Salonga D, Danenberg KD, Danenberg PV. Correlation between thymidylate synthase (TS) genotype, clinical outcome, and TS mRNA expression in subjects treated with oxaliplatin (OX) and capecitabine (Cape) Journal of Clinical Oncology. 24: 13073-13073. DOI: 10.1200/Jco.2006.24.18_Suppl.13073  0.35
2006 Uchida K, Hayashi K, Kuramochi H, Kudo K, Miyakura S, Fujita I, Yamamoto M, Danenberg KD, Danenberg PV, Takasaki K. ERCC1 expression as a predictor for chemosensitivity in recurrent colorectal cancer patients receiving cisplatinum (CDDP) plus S-1 chemotherapy Journal of Clinical Oncology. 24: 13065-13065. DOI: 10.1200/Jco.2006.24.18_Suppl.13065  0.433
2006 Harpole DH, Joshi MM, Petersen RP, Conlon DH, Tanaka K, Shimizu D, Kuramochi H, Williams M, Danenberg PV, Danenberg K. A lung cancer genomic risk prediction model derived from paraffin-embedded tissue Journal of Clinical Oncology. 24: 10059-10059. DOI: 10.1200/Jco.2006.24.18_Suppl.10059  0.393
2005 Chen LC, Krug LM, Azzoli CG, Park SJ, Gomez J, Danenberg K, Danenberg P, Kris MG. Measurements of total DNA and methylated tumor suppressor genes in the plasma of patients with small cell lung cancer (SCLC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7162. PMID 27944984 DOI: 10.1200/Jco.2005.23.16_Suppl.7162  0.386
2005 Artinyan A, Essani R, Lake J, Kaiser AM, Vukasin P, Danenberg P, Danenberg K, Haile R, Beart RW. Molecular predictors of lymph node metastasis in colon cancer: increased risk with decreased thymidylate synthase expression. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 9: 1216-21; discussion . PMID 16332476 DOI: 10.1016/J.Gassur.2005.06.028  0.393
2005 Lord RV, Brabender J, Wickramasinghe K, DeMeester SR, Holscher A, Schneider PM, Danenberg PV, DeMeester TR. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. Surgery. 138: 924-31. PMID 16291394 DOI: 10.1016/J.Surg.2005.05.007  0.359
2005 Vallböhmer D, Peters JH, Oh D, Kuramochi H, Shimizu D, Demeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, DeMeester TR, Danenberg P. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma. Surgery. 138: 701-6; discussion 70. PMID 16269299 DOI: 10.1016/J.Surg.2005.06.051  0.41
2005 Brabender J, Marjoram P, Lord RV, Metzger R, Salonga D, Vallböhmer D, Schäfer H, Danenberg KD, Danenberg PV, Selaru FM, Baldus SE, Hölscher AH, Meltzer SJ, Schneider PM. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 2113-7. PMID 16172218 DOI: 10.1158/1055-9965.Epi-05-0014  0.35
2005 Shimizu D, Ishikawa T, Ichikawa Y, Togo S, Hayasizaki Y, Okazaki Y, Danenberg PV, Shimada H. Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays. International Journal of Oncology. 27: 371-6. PMID 16010417 DOI: 10.3892/Ijo.27.2.371  0.417
2005 Miyoshi Y, Uemura H, Ishiguro H, Kitamura H, Nomura N, Danenberg PV, Kubota Y. Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer Prostate Cancer and Prostatic Diseases. 8: 260-265. PMID 15999119 DOI: 10.1038/Sj.Pcan.4500817  0.368
2005 Kakimoto M, Uetake H, Osanai T, Shirota Y, Takagi Y, Takeshita E, Toriya Y, Danenberg K, Danenberg PV, Sugihara K. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test. Cancer Letters. 223: 103-11. PMID 15890242 DOI: 10.1016/J.Canlet.2004.09.020  0.411
2005 Uchida K, Schneider S, Yochim JM, Kuramochi H, Hayashi K, Takasaki K, Yang D, Danenberg KD, Danenberg PV. Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to fluoropyrimidine-based chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 3363-8. PMID 15867236 DOI: 10.1158/1078-0432.Ccr-04-1650  0.721
2005 Haile RW, Yochim JM, Cortessis VK, Lin J, Levine AJ, Diep A, Danenberg K, Danenberg P. A molecular/epidemiologic analysis of expression of cyclooxygenases 1 and 2, use of nonsteroidal antiinflammatory drugs, and risk of colorectal adenoma. Clinical Colorectal Cancer. 4: 390-5. PMID 15807932 DOI: 10.3816/Ccc.2005.N.011  0.683
2005 Joshi MB, Shirota Y, Danenberg KD, Conlon DH, Salonga DS, Herndon JE, Danenberg PV, Harpole DH. High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 2215-21. PMID 15788669 DOI: 10.1158/1078-0432.Ccr-04-1387  0.4
2005 Schneider S, Uchida K, Brabender J, Baldus SE, Yochim J, Danenberg KD, Salonga D, Chen P, Tsao-Wei D, Groshen S, Hoelscher AH, Schneider PM, Danenberg PV. Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer. Journal of the American College of Surgeons. 200: 336-44. PMID 15737843 DOI: 10.1016/J.Jamcollsurg.2004.10.035  0.438
2005 Brabender J, Metzger R, Salonga D, Danenberg KD, Danenberg PV, Hölscher AH, Schneider PM. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis. Carcinogenesis. 26: 525-30. PMID 15618235 DOI: 10.1093/Carcin/Bgi006  0.458
2005 Azzoli CG, Park S, Gomez J, Krug L, Miller V, Rizvi N, Ben-Porat L, Danenberg K, Danenberg P, Kris M. Measurements of total DNA and methylated tumor suppressor genes in the plasma of patients with metastatic non-small cell lung cancer (NSCLC) before, and after chemotherapy, as potential biomarkers for response to treatment Journal of Clinical Oncology. 23: 7203-7203. DOI: 10.1200/Jco.2005.23.16_Suppl.7203  0.365
2005 Grem JL, Uchida K, Salonga D, Danenberg P, Danenberg K. Thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), ERCC1, & thymidine phosphorylase gene expression in primary & metastatic (met) colorectal cancer (CRC) tissue in patients (pts) treated on a phase I trial of oxaliplatin (OX) & capecitabine (Xel) Journal of Clinical Oncology. 23: 3549-3549. DOI: 10.1200/Jco.2005.23.16_Suppl.3549  0.428
2005 Chen L, Krug L, Azzoli C, Cheung I, Park S, Danenberg P, Danenberg K, Cheung N, Kris M. P-752 Biomarkers for small cell lung cancer (SCLC): DNA methylationand GD2 synthase transcript levels Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)81245-0  0.345
2004 Yang D, Schneider S, Danenberg KD, Danenberg PV, Lenz HJ. Gene expressions of VEGF and Survivin as molecular markers of lymph node involvement in patients with locally advanced rectal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 9526. PMID 28016837 DOI: 10.1200/Jco.2004.22.14_Suppl.9526  0.342
2004 Uchida K, Hayashi K, Danenberg KD, Schneider S, Kuramochi H, Takasaki K, Danenberg PV. Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to chemotherapy with S-1 as well as a prognostic factor for survival of patients after S-1 chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3642. PMID 28014592 DOI: 10.1200/Jco.2004.22.14_Suppl.3642  0.449
2004 Kuramochi H, Vallböhmer D, Uchida K, Schneider S, Hamoui N, Shimizu D, Chandrasoma PT, DeMeester TR, Danenberg KD, Danenberg PV, Peters JH. Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 8: 1007-16; discussion . PMID 15585388 DOI: 10.1016/J.Gassur.2004.09.025  0.418
2004 Danenberg PV. Pharmacogenomics of thymidylate synthase in cancer treatment. Frontiers in Bioscience : a Journal and Virtual Library. 9: 2484-94. PMID 15353301 DOI: 10.2741/1410  0.447
2004 Hamoui N, Peters JH, Schneider S, Uchida K, Yang D, Vallböhmer D, Valboehmer D, Hagen JA, DeMeester SR, DeMeester TR, Danenberg K, Danenberg P. Increased acid exposure in patients with gastroesophageal reflux disease influences cyclooxygenase-2 gene expression in the squamous epithelium of the lower esophagus. Archives of Surgery (Chicago, Ill. : 1960). 139: 712-6; discussion 71. PMID 15249402 DOI: 10.1001/Archsurg.139.7.712  0.372
2004 Schneider S, Uchida K, Salonga D, Yochim JM, Danenberg KD, Danenberg PV. Quantitative determination of p16 gene expression by RT-PCR. Methods in Molecular Biology (Clifton, N.J.). 281: 91-103. PMID 15220523 DOI: 10.1385/1-59259-811-0:091  0.688
2004 Warnecke-Eberz U, Metzger R, Miyazono F, Baldus SE, Neiss S, Brabender J, Schaefer H, Doerfler W, Bollschweiler E, Dienes HP, Mueller RP, Danenberg PV, Hoelscher AH, Schneider PM. High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 3794-9. PMID 15173087 DOI: 10.1158/1078-0432.Ccr-03-0079  0.384
2004 Brabender J, Lord RV, Metzger R, Park J, Salonga D, Danenberg KD, Hölscher AH, Danenberg PV, Schneider PM. Role of retinoid X receptor mRNA expression in Barrett's esophagus. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 8: 413-22. PMID 15120365 DOI: 10.1016/J.Gassur.2004.02.007  0.408
2004 Brabender J, Marjoram P, Salonga D, Metzger R, Schneider PM, Park JM, Schneider S, Hölscher AH, Yin J, Meltzer SJ, Danenberg KD, Danenberg PV, Lord RV. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. Oncogene. 23: 4780-8. PMID 15107828 DOI: 10.1038/Sj.Onc.1207663  0.39
2004 Hillenbrand A, Formentini A, Staib L, Sander S, Salonga D, Danenberg K, Danenberg P, Kornmann M. A longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving hepatic arterial infusion chemotherapy. Ejso. 30: 407-413. PMID 15063894 DOI: 10.1016/J.Ejso.2004.01.012  0.354
2004 Schneider S, Yochim J, Brabender J, Uchida K, Danenberg KD, Metzger R, Schneider PM, Salonga D, Hölscher AH, Danenberg PV. Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 1588-96. PMID 15014008 DOI: 10.1158/1078-0432.Ccr-0565-3  0.448
2004 Uchida K, Hayashi K, Kawakami K, Schneider S, Yochim JM, Kuramochi H, Takasaki K, Danenberg KD, Danenberg PV. Loss of heterozygosity at the thymidylate synthase (TS) locus on chromosome 18 affects tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 433-9. PMID 14760062 DOI: 10.1158/1078-0432.Ccr-0200-03  0.644
2004 Half E, Broaddus R, Danenberg KD, Danenberg PV, Ayers GD, Sinicrope FA. HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors. International Journal of Cancer. 108: 540-8. PMID 14696118 DOI: 10.1002/Ijc.11599  0.412
2004 Somlo G, Schneider S, Chu P, Ye W, Frankel P, Ruel C, Doroshow JH, Danenberg K, Danenberg P. Gene and protein expression profile and prognosis in high-risk primary breast cancer Journal of Clinical Oncology. 22: 9569-9569. DOI: 10.1200/Jco.2004.22.90140.9569  0.373
2004 Shimizu D, Peters JH, Vallboehmer D, Kuramochi H, Uchida K, Schneider S, Chandrasoma PT, Danenberg KD, Demeester TR, Danenberg PV. Cyclooxygenase-2 (COX-2) mediated anti-apoptosis may occur via Bcl-2 in the progression of Barrett's esophagus to adenocarcinoma Journal of Clinical Oncology. 22: 9529-9529. DOI: 10.1200/Jco.2004.22.90140.9529  0.385
2004 Kuramochi H, Peters JH, Uchida K, Schneider S, Vallboehmer D, Shimizu D, Chandrasoma PT, Danenberg KD, Demeester TR, Danenberg P. Thymidylate synthase polymorphism in the development of Barrett's associated adenocarcinoma Journal of Clinical Oncology. 22: 9528-9528. DOI: 10.1200/Jco.2004.22.90140.9528  0.339
2004 Danenberg K, Brabender J, Schneider S, Schneider P, Metzger R, Danenberg PV. Gender differences in the predictive power of prognostic factors in NSCLC Journal of Clinical Oncology. 22: 7008-7008. DOI: 10.1200/Jco.2004.22.90140.7008  0.375
2003 Einspahr JG, Krouse RS, Yochim JM, Danenberg PV, Danenberg KD, Bhattacharyya AK, Martínez ME, Alberts DS. Association between Cyclooxygenase expression and colorectal adenoma characteristics. Cancer Research. 63: 3891-3. PMID 12873979  0.672
2003 Formenti SC, Volm M, Skinner KA, Spicer D, Cohen D, Perez E, Bettini AC, Groshen S, Gee C, Florentine B, Press M, Danenberg P, Muggia F. Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 864-70. PMID 12610186 DOI: 10.1200/Jco.2003.06.132  0.34
2003 Lord RV, Park JM, Wickramasinghe K, DeMeester SR, Oberg S, Salonga D, Singer J, Peters JH, Danenberg KD, Demeester TR, Danenberg PV. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. The Journal of Thoracic and Cardiovascular Surgery. 125: 246-53. PMID 12579092 DOI: 10.1067/Mtc.2003.203  0.305
2003 Brabender J, Schneider PM, Metzger R, Schneider S, Lord RV, Danenberg KD, Salonga D, Danenberg PV, Holscher AH. The role of retinoid X receptor mRNA expression in Barrett's esophagus and Barrett's associated adenocarcinoma of the esophagus Gastroenterology. 124. DOI: 10.1016/S0016-5085(03)83987-2  0.391
2002 Kawakami K, Ishida Y, Danenberg KD, Omura K, Watanabe G, Danenberg PV. Functional polymorphism of the thymidylate synthase gene in colorectal cancer accompanied by frequent loss of heterozygosity. Japanese Journal of Cancer Research : Gann. 93: 1221-9. PMID 12460463 DOI: 10.1111/J.1349-7006.2002.Tb01227.X  0.4
2002 Lord RV, Brabender J, Gandara D, Alberola V, Camps C, Domine M, Cardenal F, Sánchez JM, Gumerlock PH, Tarón M, Sánchez JJ, Danenberg KD, Danenberg PV, Rosell R. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 2286-91. PMID 12114432  0.307
2002 Brabender J, Lord RV, Wickramasinghe K, Metzger R, Schneider PM, Park JM, Hölscher AH, DeMeester TR, Danenberg KD, Danenberg PV. Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 6: 359-67. PMID 12022988 DOI: 10.1016/S1091-255X(02)00003-3  0.438
2002 Grem JL, Danenberg KD, Kao V, Danenberg PV, Nguyen D. Biochemical and molecular effects of UCN-01 in combination with 5-fluorodeoxyuridine in A431 human epidermoid cancer cells. Anti-Cancer Drugs. 13: 259-70. PMID 11984070 DOI: 10.1097/00001813-200203000-00008  0.309
2002 Salonga DS, Danenberg KD, Grem J, Park JM, Danenberg PV. Relative gene expression in normal and tumor tissue by quantitative RT-PCR. Methods in Molecular Biology (Clifton, N.J.). 191: 83-98. PMID 11951611 DOI: 10.1385/1-59259-189-2:83  0.392
2002 Brabender J, Park J, Metzger R, Schneider PM, Lord RV, Hölscher AH, Danenberg KD, Danenberg PV. Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer. Annals of Surgery. 235: 440-3. PMID 11882767 DOI: 10.1097/00000658-200203000-00017  0.431
2002 Formenti SC, Spicer D, Skinner K, Cohen D, Groshen S, Bettini A, Naritoku W, Press M, Salonga D, Tsao-Wei D, Danenberg K, Danenberg P. Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer. International Journal of Radiation Oncology, Biology, Physics. 52: 397-405. PMID 11872285 DOI: 10.1016/S0360-3016(01)02655-4  0.401
2001 Shirota Y, Stoehlmacher J, Brabender J, Xiong YP, Uetake H, Danenberg KD, Groshen S, Tsao-Wei DD, Danenberg PV, Lenz HJ. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy Journal of Clinical Oncology. 19: 4298-4304. PMID 11731512 DOI: 10.1200/Jco.2001.19.23.4298  0.47
2001 Brabender J, Lord RV, Danenberg KD, Metzger R, Schneider PM, Park JM, Salonga D, Groshen S, Tsao-Wei DD, DeMeester TR, Hölscher AH, Danenberg PV. Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. The Journal of Surgical Research. 99: 301-6. PMID 11469901 DOI: 10.1006/Jsre.2001.6186  0.412
2001 Brabender J, Usadel H, Danenberg KD, Metzger R, Schneider PM, Lord RV, Wickramasinghe K, Lum CE, Park J, Salonga D, Singer J, Sidransky D, Hölscher AH, Meltzer SJ, Danenberg PV. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene. 20: 3528-32. PMID 11429699 DOI: 10.1038/Sj.Onc.1204455  0.391
2001 Brabender J, Lord RV, Danenberg KD, Metzger R, Schneider PM, Uetake H, Kawakami K, Park JM, Salonga D, Peters JH, DeMeester TR, Hölscher AH, Danenberg PV. Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 5: 174-81; discussion 1. PMID 11331481 DOI: 10.1016/S1091-255X(01)80031-7  0.428
2001 Lord RV, Tsai PI, Danenberg KD, Peters JH, Demeester TR, Tsao-Wei DD, Groshen S, Salonga D, Park JM, Crookes PF, Kiyabu M, Chandrasoma P, Danenberg PV. Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence. Surgery. 129: 267-76. PMID 11231454 DOI: 10.1067/Msy.2001.110856  0.423
2001 Stoehlmacher J, Brabender J, Shirota Y, Danenberg KD, Danenberg PV, Lenz H. Epidermal growth factor receptor mRNA expression level predicts for survival in metastatic colorectal tumors Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)82462-6  0.373
2001 Brabender J, Lord RV, Tsai P, Metzger R, Schneider PM, Park J, Salonga D, Holscher AH, DeMeester TR, Danenberg KD, Danenberg PV. Glutathione S-transferase P1 mRNA expression is down-regulated in patients with Barrett's esophagus and esophageal adenocarcinoma Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)81714-3  0.352
2000 Brabender J, Lenz HJ, Danenberg PV. Molecular marker as the basis for chemotherapy? Chirurg. 71: 1433-1439. PMID 11195061 DOI: 10.1007/S001040051241  0.452
2000 Kawakami K, Brabender J, Lord RV, Groshen S, Greenwald BD, Krasna MJ, Yin J, Fleisher AS, Abraham JM, Beer DG, Sidransky D, Huss HT, Demeester TR, Eads C, Laird PW, ... ... Danenberg PV, et al. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. Journal of the National Cancer Institute. 92: 1805-11. PMID 11078757 DOI: 10.1093/Jnci/92.22.1805  0.355
2000 Link KH, Kornmann M, Butzer U, Leder G, Sunelaitis E, Pillasch J, Salonga D, Danenberg KD, Danenberg PV, Beger HG. Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy Cancer. 89: 288-296. PMID 10918158 DOI: 10.1002/1097-0142(20000715)89:2<288::Aid-Cncr13>3.0.Co;2-O  0.381
2000 Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Research. 28: E32. PMID 10734209 DOI: 10.1093/Nar/28.8.E32  0.31
2000 Lord RV, Salonga D, Danenberg KD, Peters JH, DeMeester TR, Park JM, Johansson J, Skinner KA, Chandrasoma P, DeMeester SR, Bremner CG, Tsai PI, Danenberg PV. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 4: 135-42. PMID 10675236 DOI: 10.1016/S1091-255X(00)80049-9  0.418
2000 Formenti SC, Groshen S, Florentine B, Park MJ, Danenberg PV. Low HER 2/NEU gene expression is associated with pathological response to primary paclitaxel and radiation in locally advanced breast cancer (LABC) International Journal of Radiation Oncology Biology Physics. 48: 143. DOI: 10.1016/S0360-3016(00)80080-2  0.359
2000 Brabender J, Metzger R, Danenberg KD, Schneider PM, Lord RV, Uetake H, Kawakami K, Park J, Peters JH, DeMeester TR, Hoelscher AH, Danenberg PV. Upregulation of ornithine decarboxylase MRNA expression in Barrett's esophagus Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)86388-X  0.337
2000 Brabender J, Danenberg KD, Metzger R, Lord RV, Schneider PM, Uetake H, Park J, Kawakami K, Peters JH, DeMeester TR, Hoelscher AH, Danenberg PV. Upregulation of c-myb mRNA expression in barrett's esophagus Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)82961-3  0.318
1998 Metzger R, Danenberg K, Leichman CG, Salonga D, Schwartz EL, Wadler S, Lenz HJ, Groshen S, Leichman L, Danenberg PV. High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 4: 2371-6. PMID 9796967  0.323
1998 Gorlick R, Metzger R, Danenberg KD, Salonga D, Miles JS, Longo GS, Fu J, Banerjee D, Klimstra D, Jhanwar S, Danenberg PV, Kemeny N, Bertino JR. Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 1465-9. PMID 9552053 DOI: 10.1200/Jco.1998.16.4.1465  0.399
1998 Metzger R, Leichman CG, Danenberg KD, Danenberg PV, Lenz HJ, Hayashi K, Groshen S, Salonga D, Cohen H, Laine L, Crookes P, Silberman H, Baranda J, Konda B, Leichman L. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy Journal of Clinical Oncology. 16: 309-316. PMID 9440758 DOI: 10.1200/Jco.1998.16.1.309  0.396
1998 Fisher AM, Danenberg K, Banerjee D, Bertino JR, Danenberg P, Gomer CJ. Increased photosensitivity in HL60 cells expressing wild-type p53. Photochemistry and Photobiology. 66: 265-70. PMID 9277147 DOI: 10.1111/J.1751-1097.1997.Tb08653.X  0.31
1997 Formenti SC, Dunnington G, Uzieli B, Lenz H, Keren-Rosenberg S, Silberman H, Spicer D, Denk M, Leichman G, Groshen S, Watkins K, Muggia F, Florentine B, Press M, Danenberg K, ... Danenberg P, et al. Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-fluorouracil and radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 39: 1059-68. PMID 9392545 DOI: 10.1016/S0360-3016(97)00506-3  0.358
1997 Leichman CG, Lenz HJ, Leichman L, Danenberg K, Baranda J, Groshen S, Boswell W, Metzger R, Tan M, Danenberg PV. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 15: 3223-9. PMID 9336359 DOI: 10.1200/Jco.1997.15.10.3223  0.362
1997 Hayashi K, Metzger R, Salonga D, Danenberg K, Leichman LP, Fink U, Sendler A, Kelsen D, Schwartz GK, Groshen S, Lenz HJ, Danenberg PV. High frequency of simultaneous loss of p16 and p16β gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach Oncogene. 15: 1481-1488. PMID 9333024 DOI: 10.1038/Sj.Onc.1201295  0.402
1997 Kornmann M, Link KH, Lenz HJ, Pillasch J, Metzger R, Butzer U, Leder GH, Weindel M, Safi F, Danenberg KD, Beger HG, Danenberg PV. Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy. Cancer Letters. 118: 29-35. PMID 9310257 DOI: 10.1016/S0304-3835(97)00220-6  0.384
1996 Lenz HJ, Leichman CG, Danenberg KD, Danenberg PV, Groshen S, Cohen H, Laine L, Crookes P, Silberman H, Baranda J, Garcia Y, Li J, Leichman L. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: A predictor for primary tumor response and overall survival Journal of Clinical Oncology. 14: 176-182. PMID 8558194 DOI: 10.1200/Jco.1996.14.1.176  0.437
1996 Formenti SC, Dunnington G, Lenz J, Keren-Rosenberg S, Spicer D, Danenberg K, Danenberg P. 42 Original P53 status predicts for pathological response in locally advanced breast cancer treated pre-operatively with continuous infusion (C.I.) 5-fluorouracil (5FU) during radiotherapy International Journal of Radiation Oncology Biology Physics. 36: 179. DOI: 10.1016/S0360-3016(97)85383-7  0.305
1995 Wang SJ, Scavetta R, Lenz HJ, Danenberg K, Danenberg PV, Schönthal AH. Gene amplification and multidrug resistance induced by the phosphatase-inhibitory tumor promoter, okadaic acid Carcinogenesis. 16: 637-641. PMID 7697825 DOI: 10.1093/Carcin/16.3.637  0.31
1995 Kubota Y, Shuin T, Uemura H, Fujinami K, Miyamoto H, Torigoe S, Dobashi Y, Kitamura H, Iwasaki Y, Danenberg K, Danenberg PV. Tumor suppressor gene p53 mutations in human prostate cancer Prostate. 27: 18-24. PMID 7603913 DOI: 10.1002/Pros.2990270105  0.323
1994 Lenz HJ, Danenberg K, Schnieders B, Goeker E, Peters GJ, Garrow T, Shane B, Bertino JR, Danenberg PV. Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: Marked variation of expression among leukemia patients Oncology Research. 6: 329-335. PMID 7865908  0.332
1993 Horikoshi T, Danenberg K, Volkenandt M, Stadlbauer T, Danenberg PV. Quantitative measurement of relative gene expression in human tumors. Methods of Molecular Biology. 15: 177-188. PMID 21400275 DOI: 10.1385/0-89603-244-2:177  0.375
1993 Volkenandt M, Wienecke R, Koch OM, Buer J, Probst M, Atzpodien J, Horikoshi T, Danenberg K, Danenberg P, Bertino JR. Conformational polymorphisms of cRNA of T-cell-receptor genes as a clone-specific molecular marker for cutaneous lymphoma. The Journal of Investigative Dermatology. 101: 514-6. PMID 8409516 DOI: 10.1111/1523-1747.Ep12365889  0.315
1992 Horikoshi T, Danenberg KD, Stadlbauer THW, Volkenandt M, Shea LCC, Aigner K, Gustavsson B, Leichman L, Frosing R, Ray M, Gibson NW, Spears CP, Danenberg PV. Quantitation of Thymidylate Synthase, Dihydrofolate Reductase, and DT-Diaphorase Gene Expression in Human Tumors Using the Polymerase Chain Reaction Cancer Research. 52: 108-116. PMID 1727369  0.337
1992 Volkenandt M, Dicker AP, Banerjee D, Fanin R, Schweitzer B, Horikoshi T, Danenberg K, Danenberg P, Bertino JR. Quantitation of gene copy number and mRNA using the polymerase chain reaction. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 200: 1-6. PMID 1570351 DOI: 10.3181/00379727-200-43387  0.306
1977 Danenberg PV. Thymidylate synthetase - a target enzyme in cancer chemotherapy Bba - Reviews On Cancer. 473: 73-92. PMID 145246 DOI: 10.1016/0304-419X(77)90001-4  0.317
Show low-probability matches.